ArticleBMC palliative care2026
Midazolam prescription as a trigger for potential deceased donor identification outside the ICU: a prospective feasibility study.
Article in BMC palliative care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSystematic identification of potential deceased organ donors outside the intensive care unit (ICU) remains challenging. Patients receiving palliative sedation are rarely evaluated for donation, particularly in non-critical care settings.
objectiveTo assess the operational feasibility of a semi-automated donor identification strategy triggered by midazolam prescription for end-of-life sedation outside the ICU.
methodsWe conducted a 12-month prospective, single-center feasibility study in a tertiary university hospital in Spain. A daily pharmacy-based screening system identified new midazolam prescriptions outside critical care areas. The transplant coordination team reviewed alerts, assessed medical suitability, and explored donation preferences when appropriate. When consent was obtained, intensive care to facilitate organ donation was initiated within a controlled donation after circulatory determination of death (cDCD) pathway.
resultsA total of 1,398 patients were screened (mean 3.8/day). Most alerts (94%) were excluded during rapid electronic review. Ninety-one patients underwent in-depth evaluation; 12 were medically suitable and 8 proceeded to cDCD, resulting in 19 transplanted organs. During the equivalent period in the preceding year, no referrals for organ donation originated from hospitalized palliative care services.
conclusionsA semi-automated system based on midazolam prescription is operationally feasible and can be integrated into routine hospital practice to support systematic donor identification outside the ICU.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.